A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
for Active Rheumatoid Arthritis
22 locations incl. Gilbert
Sponsor: Elevara Medicines Limited
Sex: All·Age: 18 - 75
Code: NCT07409103·Phase 2·Recruiting